Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin

Journal of Pediatric and Adolescent Gynecology

Volumn 29, Issue 5, 2016, Pages 489-495

  Fruzzetti, Franca ^a   Ghiadoni, Lorenzo ^a   Virdis, Agostino ^a   De Negri, Ferdinando ^a   Perini, Daria ^a   Bucci, Fiorella ^a   Giannarelli, Chiara ^a   Gadducci, Angiolo ^a   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Arterial stiffness; Endothelium; Fibrinolysis; Metformin; PCOS

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; HOMOCYSTEINE; INSULIN; LIPID; METFORMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLAT PROTEIN, HUMAN; SERPINE1 PROTEIN, HUMAN; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; DRUG EFFECTS; ENDOTHELIUM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; METABOLISM; POLYCYSTIC OVARY SYNDROME; PULSE WAVE; RISK FACTOR;

ADOLESCENT; ADULT; BIOMARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; ENDOTHELIUM; FEMALE; HOMOCYSTEINE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPIDS; METFORMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; PULSE WAVE ANALYSIS; RISK FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84995877242     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2016.03.004     Document Type: Article

References (37)

1. 1 Dunaif, A., Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med, 98, 1995, 33S.
2. 2 Franks, S., Polycystic ovary syndrome. N Engl J Med, 333, 1995, 853.
3. 3 Carmina, E., Cardiovascular risk and events in polycystic ovary syndrome. Climateric, 12(suppl 1), 2009, 22.
4. 4 Conway, G.S., Agrawal, R., Betteridge, D.J., et al. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol Oxf, 37, 1992, 119.
5. 5 Talbott, E., Clerici, A., Berga, S.L., et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol, 51, 1998, 415.
6. 6 Diamanti-Kandarakis, E., Dunaif, A., Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev, 33, 2012, 981.
7. 7 Orio, F. Jr., Palomba, S., Cascella, T., et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab, 89, 2004, 4588.
8. 8 Kelly, C.J., Lyall, H., Petrie, J.R., et al. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab, 87, 2002, 742.
9. 9 Kravariti, M., Naka, K.K., Kalantaridou, S.N., et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab, 90, 2005, 5088.
10. 10 Tarkun, I., Cantürk, Z., Arslan, B.C., et al. The plasminogen activator system in young and lean women with polycystic ovary syndrome. Endocr J, 51, 2004, 467.
11. 11 Carmassi, F., De Negri, F., Fioriti, R., et al. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome. Thromb Res, 116, 2005, 207.
12. 12 Alessi, M.C., Juhan-Vague, I., PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol, 26, 2006, 2200.
13. 13 Vaughan, D.E., PAI-1 and atherothrombosis. J Thromb Haemost, 3, 2005, 1879.
14. 14 Fruzzetti, F., Perini, D., Lazzarini, V., et al. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril, 92, 2009, 626.
15. 15 Carmina, E., Oberfield, S.E., Lobo, R.A., The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol, 203, 2010, 201.
16. 16 Carmina, E., Chu, M.C., Longo, R.A., et al. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab, 90, 2005, 2545.
17. 17 Ghiadoni, L., Magagna, A., Versari, D., et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension, 41, 2003, 1281.
18. 18 Gemignani, V., Faita, F., Ghiadoni, L., et al. A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging, 26, 2007, 393.
19. 19 Laurent, S., Cockcroft, J., Van Bortel, L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J, 27, 2006, 2588.
20. 20 Mancia, G., De Backer, G., Dominiczak, A., et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 25, 2007, 1105.
21. 21 Hickey, M., Balen, A., Menstrual disorders in adolescence: investigation and management. Hum Reprod Update, 9, 2003, 493.
22. 22 Van Hoof, M.H., Voorhorst, F.J., Kaptein, M.B., et al. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries for oligomenorrhea at age 18 years. Hum Reprod, 19, 2004, 383.
23. 23 Viksten-Almstromer, M., Hirschberg, A.L., Hagenfeltk, K., Prospective follow-up of menstrual disorders in adolescence and prognostic features. Acta Obstet Gynecol Scand, 87, 2007, 1162.
24. 24 Fruzzetti, F., Perini, D., Lazzarini, V., et al. Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol, 25, 2009, 335.
25. 25 Ganie, M.A., Hassan, S., Nisar, S., et al. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol, 30, 2014, 781.
26. 26 Baer, T.E., Milliren, C.E., Walls, C., et al. Clinical variability in cardiovascular disease risk factor screening and management in adolescent and young adult women with polycystic ovary syndrome. J Pediatr Adolesc Gynecol, 28, 2015, 317.
27. 27 Coviello, A.D., Legro, R.S., Dunaif, A., Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab, 91, 2006, 492.
28. 28 Devaraj, S., Xu, D.Y., Jialal, I., C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 107, 2003, 398.
29. 29 Yildiz, B.O., Haznedaroğlu, I.C., Kirazli, S., et al. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab, 87, 2002, 3871.
30. 30 Guleria, A.K., Syal, S.K., Kapoor, A., et al. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome. Gynecol Endocrinol, 30, 2014, 26.
31. 31 Carmassi, F., Morale, M., Ferrini, L., et al. Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects. Am J Med, 107, 1999, 344.
32. 32 Kuboki, K., Jiang, Z.Y., Takahara, N., et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation, 101, 2000, 676.
33. 33 Baron, A.D., Insulin resistance and vascular function. J Diabetes Complications, 16, 2002, 92.
34. 34 Domecq, J.P., Prutsky, G., Mullan, R.J., et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab, 98, 2013, 4655.
35. 35 Orio, F. Jr., Palomba, S., Cascella, T., et al. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. J Clin Endocrinol Metab, 90, 2005, 6072.
36. 36 Ferrannini, E., Buzzigoli, G., Bonadonna, R., et al. Insulin resistance in essential hypertension. N Engl J Med, 317, 1987, 350.
37. 37 Izzo, J.L. Jr., Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol, 19, 2004, 341.